Meet our new, next-level CGM.
FOR ALL AUSTRALIANS WITH DIABETES
Everything you love about FreeStyle Libre 2 …
Subsidised through the NDSS for Australians with type 1 diabetes, from 1 April 2025
( eligibility criteria applies)
PLUS
+ Extended 15-day wear time: 50 % longer wear time than other CGMs in Australia *
+ Improved accuracy: our most accurate sensor #, 1
+ Will pair with the Omnipod ® 5 System for a seamless Automated Insulin Delivery( AID) experience. ^ Stay tuned for updates!
HEALTHCARE PROFESSIONALS- LEARN MORE
FreeStyleConnect. com. au
FreeStyleLibre2Plus. com. au
This product is indicated for measuring interstitial fluid glucose levels in people( aged 2 +) with diabetes. * Compared to other on-market CGMs in Australia. As of March, 2025.
^ The FreeStyle Libre 2 Plus sensor will work with the Omnipod ® 5 System in the near future. Please visit FreeStyleLibre. com. au for updates or call 1800 801 478 for more information. The Omnipod ® 5 Automated Insulin Delivery System is indicated for use by individuals with Type 1 diabetes mellitus in persons 2 years of age and older.
# Compared to the FreeStyle Libre 2 sensor. 1. U. S. Food and Drug Administration( FDA). 510( k) K222447. 2023. https:// www. accessdata. fda. gov / cdrh _ docs / reviews / K222447. pdf. Accessed 1 Dec 2024.
The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Information contained herein is for distribution outside of the USA only. Omnipod ® is a registered trademark of Insulet Corporation and used with permission. Other trademarks are the property of their respective owners. The FreeStyle Libre 2 Plus sensor is authorised to work with the Omnipod ® 5 Automated Insulin Delivery System. Abbott Australasia Pty. Ltd., Abbott Diabetes Care, 666 Doncaster Road, Doncaster, Victoria 3108, Australia. ABN 95 000 180 389. ADC-110764 V1.0
POLY16438